What is AVP-923 (DM/Q)?
CATEGORY:
A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy and to Determine the Pharmacokinetics of Two Doses of AVP-923 (Dextromethorphan/Quinidine) in the Treatment of Pseudobulbar Affect (PBA) in Patients With Amyotrophic Lateral Sclerosis and Multiple Sclerosis
Save up to 80% off your prescriptions!
How do members experience AVP-923 (DM/Q)?
Top 5 reported purposes & perceived effectiveness
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Emotional lability | 3 | 1 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Headaches | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 1 | |
| None | 0 |
Member evaluations
a
aehmlhmrh
evaluated on Feb 17, 2010
- Perceived effectiveness for emotional lability: Major
- Side effects: Mild
Learn more about our community’s experience with AVP-923 (DM/Q)
What are people saying about AVP-923 (DM/Q)?
4
4
members have reported taking AVP-923 (DM/Q)
Join the conversation and connect with people who have taken AVP-923 (DM/Q)
Last updated: